Publicaciones en las que colabora con Aleix Prat (6)

2021

  1. Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial

    npj Breast Cancer, Vol. 7, Núm. 1

  2. The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers

    npj Breast Cancer, Vol. 7, Núm. 1

2016

  1. Modeling anti-IL-6 therapy using breast cancer patient-derived xenografts

    Oncotarget, Vol. 7, Núm. 42, pp. 67956-67965

2015

  1. Gene expression-based classifications of fibroadenomas and phyllodes tumours of the breast

    Molecular Oncology, Vol. 9, Núm. 6, pp. 1081-1090

2014

  1. Effect of p95HER2/611CTF on the response to trastuzumab and chemotherapy

    Journal of the National Cancer Institute, Vol. 106, Núm. 11

2012

  1. PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition

    Cancer Discovery, Vol. 2, Núm. 11, pp. 1036-1047